We are live on
!
Find out more
N
Natixis Portfolio holdings
AUM
$28B
1-Year Est. Return
26.79%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter
Est. Return
+3.8%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$13B
AUM Growth
-$2.88B
(-18%)
Cap. Flow
-$3.34B
Cap. Flow
% of AUM
-25.66%
Top 10 Holdings %
Top 10 Hldgs %
27.65%
Holding
969
New
188
Increased
241
Reduced
265
Closed
254
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$250M |
| 2 |
JD.com
JD
|
+$200M |
| 3 |
Merck
MRK
|
+$151M |
| 4 |
Broadcom
AVGO
|
+$115M |
| 5 |
Philip Morris
PM
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$339M |
| 2 |
Meta Platforms (Facebook)
META
|
+$321M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$288M |
| 4 |
Boeing
BA
|
+$260M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$234M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.69% |
| 2 | Communication Services | 11.21% |
| 3 | Consumer Discretionary | 10.35% |
| 4 | Financials | 10.01% |
| 5 | Technology | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Terex
TEX
$7.98B
| $2.19M | 0.02% |
+69,901
| New | +$2.15M |
|
|
SINA
427
DELISTED
Sina Corp
SINA
| $2.19M | 0.02% |
50,684
+43,783
| +634% | +$2.3M |
|
428
Cadence Design Systems
CDNS
$90B
| $2.18M | 0.02% |
30,789
+22,370
| +266% | +$1.5M |
|
|
LOGM
429
DELISTED
LogMein, Inc.
LOGM
| $2.18M | 0.02% |
+29,536
| New | +$2.28M |
|
|
SJR
430
DELISTED
Shaw Communications Inc.
SJR
| $2.17M | 0.02% |
106,344
+84,528
| +387% | +$1.72M |
|
431
John Wiley & Sons Class A
WLY
$2.52B
| $2.17M | 0.02% |
47,373
-23,579
| -33% | -$1.07M |
|
432
Teva Pharmaceuticals
TEVA
$35.9B
| $2.17M | 0.02% |
235,274
+167,083
| +245% | +$2.01M |
|
433
Citigroup
C
$222B
| $2.17M | 0.02% |
30,962
-1,031,115
| -97% | -$69M |
|
|
VAR
434
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.16M | 0.02% |
+15,890
| New | +$2.12M |
|
|
NUAN
435
DELISTED
Nuance Communications, Inc.
NUAN
| $2.15M | 0.02% |
155,136
+22,722
| +17% | +$335K |
|
436
Healthpeak Properties
DOC
$15.4B
| $2.1M | 0.02% |
65,748
-245,139
| -79% | -$7.62M |
|
437
RH
RH
$3.3B
| $2.09M | 0.02% |
18,088
-60,957
| -77% | -$6.29M |
|
438
iShares MSCI EAFE ETF
EFA
$76.4B
| $2.08M | 0.02% |
31,677
-494,073
| -94% | -$32.3M |
|
439
Morgan Stanley
MS
$337B
| $2.06M | 0.02% |
47,119
-1,638,327
| -97% | -$73.1M |
|
|
NEWR
440
DELISTED
New Relic, Inc.
NEWR
| $2.05M | 0.02% |
23,716
-3,150
| -12% | -$311K |
|
441
Lumen
LUMN
$6.53B
| $2.04M | 0.02% |
+173,478
| New | +$1.95M |
|
442
Toro Company
TTC
$8.93B
| $2.03M | 0.02% |
30,409
-26,016
| -46% | -$1.83M |
|
443
Healthcare Realty
HR
$7.42B
| $2.03M | 0.02% |
+73,900
| New | +$2.08M |
|
444
Invesco
IVZ
$13.3B
| $2.02M | 0.02% |
98,992
+12,495
| +14% | +$259K |
|
445
Polaris
PII
$4.15B
| $2.02M | 0.02% |
+22,089
| New | +$2.01M |
|
|
ACGN
446
DELISTED
Aceragen Inc
ACGN
| $1.99M | 0.02% |
43,786
+16,711
| +62% | +$791K |
|
447
KLA
KLAC
$275B
| $1.97M | 0.02% |
166,330
-1,981,150
| -92% | -$22.9M |
|
|
TTM
448
DELISTED
Tata Motors Limited
TTM
| $1.95M | 0.02% |
166,698
-127,286
| -43% | -$1.73M |
|
449
Corning
GLW
$126B
| $1.95M | 0.02% |
58,563
-130,319
| -69% | -$4.18M |
|
450
Dolby
DLB
$4.72B
| $1.91M | 0.01% |
29,484
-57,166
| -66% | -$3.64M |
|
Similar funds
TWC
FDCDDQ
PCH
NA
Natixis's Q2 2019 Portfolio in Review
As of Q2 2019, Natixis held 969 positions worth $13B, down 18% from $15.9B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Natixis withdrew a net $3.34B in Q2 2019, closing 254 positions and reducing 265 holdings. Its most notable exit was Amazon, an estimated $339M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8.4% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Natixis opened a new position in Pfizer worth $258M.
- Natixis's largest Q2 2019 buy was Pfizer: 6,288,612 shares worth $258M.
- Natixis added most to JD.com in Q2 2019, an estimated $200M increase.
- Natixis's biggest Q2 2019 reduction was Meta Platforms (Facebook), cutting an estimated $321M.
- Natixis fully exited Amazon in Q2 2019, selling an estimated $339M.
- Natixis's ten largest holdings make up 28% of its $13B portfolio in Q2 2019.
- Natixis opened 188 new positions and closed 254 in Q2 2019.
- Natixis's portfolio value fell 18% quarter-over-quarter to $13B.
Based on Natixis's 13F filing for Q2 2019, filed 13 Aug 2019.